PD
IPSC icon

Point72 (DIFC)’s Century Therapeutics IPSC Stock Holding History

Point72 (DIFC)’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$530 Sell
1,064
-685
-39% -$369 ﹤0.01% 1085
2025
Q2 		$977 Buy
+1,749
New +$938 ﹤0.01% 1434
2024
Q2 		– Sell
-6,435
Closed -$26.9K – 1674
2024
Q1 		$26.9K Buy
+6,435
New +$27.2K ﹤0.01% 1272

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 (DIFC)'s IPSC Position: Q3 2025 in Review

Point72 (DIFC) reduced its Century Therapeutics (IPSC) stake by 39% in Q3 2025, selling an estimated $369 and leaving 1,064 shares worth $530. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

Point72 (DIFC) first reported a position in IPSC in Q1 2024 and has held it in 3 quarters since. The position peaked at $26.9K in Q1 2024. 57 funds tracked by Wall St. Rank hold IPSC as of Q3 2025.

  • Point72 (DIFC) held 1,064 shares of Century Therapeutics worth $530 as of Q3 2025.
  • Point72 (DIFC) sold 685 Century Therapeutics shares in Q3 2025, an estimated $369.
  • Century Therapeutics made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1085 holding.
  • Point72 (DIFC) first reported a position in Century Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Point72 (DIFC)'s Century Therapeutics position peaked at $26.9K in Q1 2024.
  • 57 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.